Summary
Breast cancer cells are exposed to insulin-like growth factors (IGFs) which stimulate their proliferation, and to IGF-binding proteins (IGFBPs) which sequester and modulate IGF action. The primary circulatory IGFBP is IGFBP-3. In the present study, cultured MCF-7 breast cancer cells regulated clearance of IGFBP-3 via both cell association and proteolysis. Exogenously added IGFBP-3 was significantly cleared from the medium over time yielding the formation of smaller sized immunodetected fragments. Clearance was inhibited by IGF-I and -II. In contrast, clearance was not affected by growth factors and an IGF-analog having mitogenic activity but not binding to IGFBPs. In fact, activity of the IGFs and analogs paralleled their degree of binding to the IGFBP, suggesting that the IGF-binding altered IGFBP-3 making it less susceptible to clearance. Qualitatively similar results were obtained when these experiments were conducted using cell-free conditioned medium, thus suggesting the presence of secreted protease(s). However, level of proteolytic activity was much less than that found in the presence of cells. Clearance of rhIGFBP-3 also involved binding to the cell. Disappearance of rhIGFBP-3 was shown to be attenuated by heparin, which blocks cell surface binding sites. In contrast, compounds which block internalization did not inhibit IGFBP-3 clearance.
References
Ahmed SR, Manni A, Gray G, Hammond JM: Characterization and hormonal regulation of radioimmunoassayable IGF-I (insulin-like growth factor I) like activity and IGF-binding proteins secreted by human breast cancer cells. Anticancer Res 10: 1217–1224, 1990
Freed KA, Herington AC: Insulin-like growth factor-I and its autocrine role in growth of MCF-7 human breast cancer cells in culture. J Mol Endocrinol 3: 183–190, 1989
Cullen KJ, Lippman ME, Chow D, Hill S, Rosen N, Zwiebel JA: Insulin-like growth factor-II overexpression in MCF-7 JA: Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol Endocrinol 6: 91–100, 1992
Yee D, Rosen N, Favoni RE, Cullen KJ: The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer. Cancer Treat Res 53: 93–106, 1991
Cullen KJ, Allison A, Martire I, Ellis M, Singer C: Insulinlike growth factor expression in breast cancer epithelium and stroma. Breast Cancer Res Treat 22: 21–29, 1992
Rosenfeld RG, Lamson G, Pham H, Oh Y, Conover C, DeLeon DD, Donovan SM, Ocrant I, Giudice L: Insulin-like growth factor-binding proteins. Recent Prog Horm Res 46: 99–163, 1990
McGuire WL Jr, Jackson JG, Figueroa JA, Shimasaki S, Powell DR, Yee D: Regulation of insulin-like growth factorbinding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. J Natl Cancer Inst 84: 1336–1341, 1992
Pratt SE, Pollak MN: Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation. Biochem Biophys Res Commun 198: 292–297, 1994
Schmid C, Rutishauser J, Schlapfer I, Froesch ER, Zapf J: Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF-I induced stimulation of osteoblasts: control of IGF signalling to bone cells by IGFBP-3-specific proteolysis? Biochem Biophys Res Commun 179: 579–585, 1991
Glikman PL, Manni A, Bartholomew M, Demers L: Polyamine involvement in basal and estradiol-stimulated insulinlike growth factor-I secretion and action in breast cancer cells in culture. J Steroid Biochem Molec Biol 37: 1–10, 1990
Oh Y, Muller HL, Lamson G, Rosenfeld RG: Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells: cell surface binding and growth inhibition. J Biol Chem 268: 14964–14971, 1993
Chen JC, Shao ZM, Sheikh MS, Hussain A, LeRoith D, Roberts CT Jr, Fontana JA: Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J Cell Physiol 158: 69–78, 1994
Kim I, Manni A, Lynch J, Hammond JM: Identification and regulation of insulin-like growth factor binding proteins produced by hormone-dependent and -independent human breast cancer cell lines. Mol Cell Endocrinol 78: 71–78, 1991
Adamo ML, Shao ZM, Lanau F, Chen JC, Clemmons DR, Roberts CT Jr, LeRoith D, Fontana JA: Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and -4 gene expression and protein secretion in a breast cancer cell line. Endocrinology 131: 1858–1866, 1992
Clemmons DR: IGF binding proteins and their functions. Mol Reprod Develop 35: 368–374, 1993
Conover CA, DeLeon DD: Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells: role of cathepsin D. J Biol Chem 269: 7076–7080, 1994
Baxter RC, Skriver L: Altered ligand specificity of proteolysed insulin-like growth factor binding protein-3. Biochem Biophys Res Commun 196: 1267–1273, 1993
Grimes RW, Hammond JM: Insulin and insulin-like growth factors (IGFs) stimulate production of IGF-binding proteins by ovarian granulosa cells. Endocrinology 131: 553–558, 1992
Grimes RW, Hammond JM: Proteolytic degradation of insulin-like growth factor (IGF)-binding protein-3 by porcine ovarian granulosa cells in culture: regulation by IGF-I. Endocrinology 134: 337–343, 1994
Walton PE, Baxter RC, Burleigh BD, Etherton TD: Purification of the serum acid-stable insulin-like growth factor binding protein from the pig (Sus scrofa). Comp Biochem Physiol 92B: 561–567, 1989
Gill JL: Design and Analysis of Experiments in the Animal and Medical Sciences, vol. 1. Ames: Iowa State University Press, 1978
Figueroa JA, Yee D: The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer. Breast Cancer Res Treat 22: 81–90, 1992
Rechler MM, Nisley SP: The nature and regulation of the receptors for insulin-like growth factors. Annu Rev Physiol 47: 425–442, 1985
Dong XF, Berthois Y, Martin PM: Effect of epidermal growth factor on the proliferation of human epithelial cancer cell lines: correlation with the level of occupied EGF receptor. Anticancer Res 11: 737–743, 1991
Smith EP, Lu L, Chernausek SD, Klein DJ: Insulin-like growth factor-binding protein-3 (IGFBP-3) concentration in rat Sertoli cell-conditioned medium is regulated by a pathway involving association of IGFBP-3 with cell surface proteoglycans. Endocrinology 135: 359–364, 1994
Martin JL, Ballesteros M, Baxter RC: Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanisms. Endocrinology 131: 1703–1710, 1992
Ballard JF, Walton PE, Bastian S, Tomas FM, Wallace JC, Francis GL: Effects of interactions between IGFBPs and IGFs on the plasma clearance andin vivo biological activities of IGFs and IGF analogs. Growth Regul 3: 40–44, 1993
Oh Y, Muller HL, Pham H, Lamson G, Rosenfeld RJ: Insulin-like growth factor binding protein (IGFBP)-3 levels in conditioned media of Hs578T human breast cancer cells are post-transcriptionally regulated. Growth Regul 3: 84–87, 1993
Rochefort H, Capony F, Garcia M: Cathepsin D: a protease involved in breast cancer metastasis. Cancer Metastasis Rev 9: 321–331, 1990
Frost VJ, Macaulay VM, Wass JA, Holly JM: Proteolytic modification of insulin-like growth factor-binding proteins: comparison of conditioned media from human cell lines, circulating proteases and characterized enzymes. J Endocrinol 138: 545–554, 1993
Oh Y, Muller HL, Pham H, Rosenfeld RG: Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 269: 26045–26048, 1993
Campbell PG, Novak JF, Wines K, Walton PE: Localization of plasmin activity on osteosarcoma cells: cell surface proteolysis of insulin-like growth factor binding proteins. Growth Regul 3: 95–98, 1993
Conover CA: Potentiation of insulin-like growth factor (IGF) action by IGF binding protein-3: studies of an underlying mechanism. Endocrinology 130: 3191–3200, 1992
Lamson G, Giudice LC, Cohen P, Liu F, Gargosky S, Muller H, Oh Y, Wilson KF, Hintz RL, Rosenfeld RG: Proteolysis of IGFBP-3 may be a common regulatory mechanism of IGF actionin vivo. Growth Regul 3: 91–95, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grimes, R.W., Manni, A. & Hammond, J.M. Postsynthetic regulation of insulin-like growth factor-binding protein-3 by MCF-7 human breast cancer cells in culture. Breast Cancer Res Tr 39, 187–196 (1996). https://doi.org/10.1007/BF01806185
Issue Date:
DOI: https://doi.org/10.1007/BF01806185